CAV1 expression was also found to be high in methotrexate-resistant HT29 colon-cancer cells, and its downregulation by siRNA concomitant with overexpression of E-cadherin significantly reduced cell viability suggesting that these are potential targets for combination therapy in colon cancer [82]. This evidence concerns the gene CAV1 and colonic neoplasm.